USFDA inspection at manufacturing facility of Medispray in Kundaim, Goa, India

The United States Food and Drugs Administration ('USFDA') has conducted an inspection at the manufacturing facility of Medispray Laboratories Private Limited, wholly owned subsidiary of Cipla Limited ('Medispray') located in Kundaim, Goa from 14th - 20th January, 2025.

On conclusion of the inspection, Medispray received 1 (one) observation in Form 483. The Company will work closely with the USFDA and remains committed to address these observations comprehensively within stipulated time.

Shares of Cipla Limited was last trading in BSE at Rs. 1445.90 as compared to the previous close of Rs. 1442.45. The total number of shares traded during the day was 13277 in over 1723 trades.

The stock hit an intraday high of Rs. 1449.75 and intraday low of 1429.75. The net turnover during the day was Rs. 19151454.00.

Source : Equity Bulls

Keywords

Cipla INE059A01026 MedisprayLaboratories USFDA Inspection Form483 OneObservation